Preoperative TACE with PD-1 inhibitors and TKIs in beyond “up-to-seven” hepatocellular carcinoma: a propensity score matched analysis
Preoperative TACE with PD-1 inhibitors and TKIs was associated with improved survival without increasing severe complications in beyond "up-to-seven" HCC, suggesting a promising perioperative strategy for high-risk patients.
Authors
- YaHui Chen (ORCID: https://orcid.org/0009-0009-0184-9536)
- Qinyan Yang (ORCID: https://orcid.org/0000-0002-1835-4355)
- Yuxin Liang (ORCID: https://orcid.org/0000-0001-6872-5030)
- Yuhao Su
- Deyuan Zhong
- Hongtao Yan
- Xiaolun Huang (ORCID: https://orcid.org/0000-0002-4993-0802)
- Ming Wang
Institutions
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.3389/fimmu.2025.1657371
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Science and Technology of Sichuan Province